Shrikant V Mukewar

机构：Midas Multispeciality Hospital

发表论文 42 篇 · 总被引 1660 次 · h-index 10

代表论文

• Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study (2024 · The Lancet · 被引 114)
• Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease (2022 · Metabolic Syndrome and Related Disorders · 被引 35)
• Patients with metabolic-dysfunction associated fatty liver disease (MAFLD) without associated etiologies and non-MAFLD non-alcoholic fatty liver disease (NAFLD) have similar liver disease severity - Data from Indian Consortium on NAFLD (ICON-D). (2022 · Journal of Clinical and Experimental Hepatology · 被引 4)
• Endoscopic resection of a large ampullary tumor using a hybrid endoscopic submucosal dissection and mucosal resection technique (2023 · Endoscopy · 被引 3)
• Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study (2026 · Journal of Clinical and Experimental Hepatology · 被引 2)
• Endoscopic Management of a Complex Biliary Problem (2023 · Journal of Digestive Endoscopy · 被引 2)